Pr ecis: This study provides a new perspective on the inherent risks of interventional chemotherapy in cancer patients by showing how the adaption of unstable cell populations exposed to antiproliferative drugs can be acted upon by selective forces that drive the outgrowth of rapidly proliferative drug-resistant cell populations.
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Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer Yoray Sharon, Yael Raz, Noam Cohen, Amir Ben-Shmuel, Hila Schwartz, Tamar Geiger, and Neta Erez Pr ecis: These findings deepen the causative influence of a proinflammatory protein secreted by breast carcinoma cells in programming a supportive role for fibroblasts in the tumor microenvironment, with implications for understanding the etiology of advanced cancer and its therapeutic management by renormalization of the tissue microenvironment. Pr ecis: A signaling axis that conditions the inflammatory microenvironment in breast cancer helps drive the aggressive growth of these tumors, including deadly triple-negative tumors that occur more commonly in premenopausal women.
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TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression
Shinan Li, Rui Sun, Yongyan Chen, Haiming Wei, and Zhigang Tian Pr ecis: These findings illuminate a mechanism of immunosuppression in liver carcinogenesis that may assist the design of effective immunotherapies to treat hepatocellular carcinoma. Pr ecis: Understanding the activation status of various oncogenic drivers as they exist in specific treatment contexts in vivo may be important to achieve beneficial outcomes, increasing the complexity in how to use targeted drugs that were designed only with cancer cells in mind.
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Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis Pr ecis: A tumor suppressor gene that functions in glioma stem-like cells acts to inhibit their expression of tissue plasminogen activator, with the provocative implication that targeting this central coagulation factor may ablate cancer stem-like functions in the brain.
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Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression
Afshin Beheshti, S ebastien Benzekry, J. Tyson McDonald, Lili Ma, Michael Peluso, Philip Hahnfeldt, and Lynn Hlatky
Pr ecis: This study offers direct support for age dependence in determining the host tumor control dynamic and provides initial mechanism-based insights into how aging modulates tumor progression in ways that may be actionable for therapy or prevention. 
